Researchers analyze media’s cancer reporting

Share:

University of Pennsylvania researchers reviewed 436 cancer-related newspaper and magazine stories (about 1/5 of the total) published between 2005 and 2007 and found that media tend to overhype aggressive treatments and avoid failures, errors, end of life care and death. Here’s the abstract in Archives of Internal Medicine.

In the press release, the study’s highlights are summarized thus:

  • Although 32 percent of the articles focused on survival, only 8 percent covered death and dying; this despite the fact that half of all cancer patients will die of their illness.
  • While most stories discussed aggressive cancer treatments, almost none (2 percent) discussed end-of-life, palliative or hospice care.
  • 13 percent reported that aggressive cancer treatments can fail, and just 30 percent reported that aggressive treatments can result in adverse effects.

The authors note that the media under-reports palliative and hospice care, as well as outcomes data and other issues surrounding death and dying.

The study notes that unrealistic optimism is presented in most stories about cancer treatment, when in reality half of all cancer patients do not survive, according to statistics from the American Cancer Society.

“The nation’s leading media institutions have set a low bar for routine coverage of the nation’s long-running war on cancer. Hype is the norm,” wrote medical author Merrill Goozner, MS, in a commentary accompanying the article. “The relationship between journalism and medical researchers has been called a complicit collaboration in which both benefit from sensationalized stories. Recent media cutbacks and the evolution of a hyper speed news cycle only made things worse.”

“The tendency of the news to report on aggressive cancer treatments and survival, but not on alternatives, is … noteworthy given that unrealistic information may mislead the public about the trade-offs between attempts at heroic cures and hospice care,” the authors of the study wrote.

Andrew Van Dam